Hpgc Renmintongtai Pharmaceutical Corporation Class ASSE: 600829

Report for Q3 2024

Oct 22, 2024 · Issued by Hpgc Renmintongtai Pharmaceutical Corporation Class A via Shanghai Stock Exchange

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment